Miricor Enterprises Holdings Ltd (HK:1827)
:1827
Want to see HK:1827 full AI Analyst Report?
1827 Stock Chart & Stats
HK$0.95
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.95
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.08 - HK$1.30
Previous CloseN/A
Volume40.00K
Average Volume (3M)4.67K
Market Cap
HK$360.00M
Enterprise ValueHK$266.44M
Total Cash (Recent Filing)HK$192.17M
Total Debt (Recent Filing)HK$88.76M
Price to Earnings (P/E)33.1
Beta-0.15
Next Earnings
Jun 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding400,000,000
10 Day Avg. Volume6,000
30 Day Avg. Volume4,666
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)3.17
Price to Sales (P/S)1.16
P/FCF Ratio4.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationOperating and free cash flow were strong in 2025 and FCF nearly matched net income, indicating high earnings quality. Durable cash generation improves financial flexibility to fund capex, reduce debt, support expansion of clinics and product inventory, and withstand demand cycles.
High Gross Margins And Return To ProfitA sustained gross margin above 50% and a return to operating profit reflect service pricing power and favorable product mix. Strong services margins in aesthetic medicine support durable profitability even with volume fluctuations, enabling reinvestment in clinics and client retention programs.
Improving, Manageable LeverageLeverage has declined to a debt-to-equity around 0.60, easing balance-sheet risk. A more conservative capital structure increases resilience to revenue volatility, preserves borrowing capacity for strategic investments, and reduces refinancing pressure during market stress.
Bears Say
Recent Revenue DeclineRevenue fell about 6% in 2025, signaling demand or volume pressure in core aesthetic services. Persistent top-line weakness undermines the sustainability of margin and profit recovery, limits operating leverage, and constrains the company’s ability to scale clinic network or increase marketing investment.
Earnings Volatility And Prior LossesThe company posted losses in 2023–2024 before a 2025 recovery, indicating earnings have been volatile. This episodic profitability complicates forecasting, reduces compounded equity growth, and raises execution risk for sustaining investment in service expansion and product R&D over the medium term.
Multi-year Revenue ContractionMulti-year revenue growth is deeply negative (~-20.6%), reflecting a material shrinkage of scale over the measured period. Structural top-line contraction risks market share erosion, pressures fixed-cost absorption, and could force margin trade-offs that weaken long-term profitability unless growth reverses.
Miricor Enterprises Holdings Ltd News
1827 FAQ
What was Miricor Enterprises Holdings Ltd’s price range in the past 12 months?
Miricor Enterprises Holdings Ltd lowest stock price was HK$0.08 and its highest was HK$1.30 in the past 12 months.
What is Miricor Enterprises Holdings Ltd’s market cap?
Miricor Enterprises Holdings Ltd’s market cap is HK$360.00M.
When is Miricor Enterprises Holdings Ltd’s upcoming earnings report date?
Miricor Enterprises Holdings Ltd’s upcoming earnings report date is Jun 30, 2026 which is in 40 days.
How were Miricor Enterprises Holdings Ltd’s earnings last quarter?
Miricor Enterprises Holdings Ltd released its earnings results on Nov 25, 2025. The company reported -HK$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.001.
Is Miricor Enterprises Holdings Ltd overvalued?
According to Wall Street analysts Miricor Enterprises Holdings Ltd’s price is currently Overvalued.
Does Miricor Enterprises Holdings Ltd pay dividends?
Miricor Enterprises Holdings Ltd does not currently pay dividends.
What is Miricor Enterprises Holdings Ltd’s EPS estimate?
Miricor Enterprises Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Miricor Enterprises Holdings Ltd have?
Miricor Enterprises Holdings Ltd has 400,000,000 shares outstanding.
What happened to Miricor Enterprises Holdings Ltd’s price movement after its last earnings report?
Miricor Enterprises Holdings Ltd reported an EPS of -HK$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Miricor Enterprises Holdings Ltd?
Currently, no hedge funds are holding shares in HK:1827
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Miricor Enterprises Holdings Ltd
Miricor Enterprises Holdings Limited, an investment holding company, provides medical aesthetic services in Hong Kong. It also offers a range of non-surgical medical aesthetic services, including energy-based and injection procedures. The company operates three medical aesthetic centers under the CosMax+ name. It also sells skin care products, such as cleansers, toners, serums, moisturizers, eye care products, ultraviolet protection products, and masks. Miricor Enterprises Holdings Limited was founded in 2009 and is headquartered in Causeway Bay, Hong Kong.
Technical Analysis
Fu Shou Yuan International Group
―
Modern Healthcare Technology Holdings Limited
―
Perfect Medical Health Management Limited
―
Max Sight Group Holdings Limited
―
Shenghui Cleanness Group Holdings Limited
―